X
Feb 14, 2022 05:00 PM (GMT+8) · EqualOcean
Humanwell pharmaceutical announced that Yichang humanwell Pharmaceutical Co., Ltd. (hereinafter referred to as "Yichang humanwell"), the holding subsidiary of the company, recently received the drug registration certificate of memantine hydrochloride sustained-release capsule approved and issued by the food and drug administration. Memantine hydrochloride sustained release capsule is used to treat moderate to severe Alzheimer's dementia.